Group items tagged

Market Overview: Skin substitutes are natural, synthetic or biosynthetic materials, used to cover large wounds to restore at least some of the functions of the skin. Skin substitutes provides temporary or permanent wound closure and protect the wound from infection, further damage and water loss, and reduce pain. They also facilitate the growth of the normal skin over the wound. Skin substitutes provide a permanent solution and are used in the treatment of conditions like burns, trauma wounds, diabetes or venous ulcers, where skin grafts may not be possible. Market Dynamics: Rising chronic skin diseases is expected to drive the skin substitutes market. For instance, according to the global burden of disease study 2013, Skin conditions contributed around 1.79% to the global disease burden. According to the World Health Organization, about 132,000 melanoma skin cancers occur each year worldwide. Thus, the rising chronic diseases is increasing the demand for skin substitutes in the forecast period. Rising prevalence of diabetes is expected to boost the market. This is owing to the risk of developing a diabetic foot ulcer over the period of time in diabetic patients. For instance, WHO has reported that the incidence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is anticipated to rise from 171 million in 2000 to 366 million in 2030. Thus, as a consequence, the prevalence of diabetes related complications are expected to increase over the forecast period. There are several limitations to the commercially available skin substitutes, like reduced vascularization, poor mechanical integrity, failure to integrate, scarring, and immune rejection. Market Segmentation: Rise in preference for acellular skin substitutes to implant-based skin surgery is expected to drive the growth of the skin substitutes market. For instance, the American Society of Plastic Surgeons in 2012, reported that

Companion animals are domesticated or domestic-bred animals whose physical, emotional, behavioral and social needs can be readily met as companions in the home or a close daily relationship with humans. Companion animal health market mainly comprises of medicines, medicinal feed additives, and vaccines and caters to both foods producing and companion animals. China Companion Animal Health Market was worth US$ XX Million in 2019 and is expected to reach US$ XX Million by 2026, at a CAGR of XX% during the forecast period 2019-2026. Download Free Sample Report: https://www.datamintelligence.com/download-sample/china-companion-animal-health-market View Full Report Sample: https://www.datamintelligence.com/research-report/china-companion-animal-health-market

Market Overview: Next-generation antibody therapeutics includes the use of new improvised therapeutic antibody to form innovative medicines for treating various diseases. Next-generation antibody therapeutics is developed clinically by pharmaceutical and biotechnology companies for several diseases. The Next Generation Antibody Therapeutics Market size was worth $ XX million in 2018 and is forecasted to reach $ XX million by 2026, expected to grow at a high CAGR during the forecast period 2019-2026. Market Dynamics: The Next Generation Antibody Therapeutics Market is growing due to several factors such as rising incidence of chronic diseases, increasing emergence of antibody technology, new drug discovery, large number of government initiatives, and growing research and development activities for new therapies. Rising prevalence of chronic disease such as cancer, asthma, diabetes and COPD are boosting the growth of the next generation antibody therapeutics market. For instance, according to National Cancer Institute in 2018, in United States, an estimated 1,735,350 new cases of cancer will be diagnosed and 609,640 people will die from the disease. The development of next-generation monoclonal antibodies has expanded beyond oncology into all therapeutic areas. For instance, ADCs were initially focused primarily on cancer, but Genentech has applied to infectious diseases, leading to the discovery and development of THIOMAB antibiotic conjugates (TACs) for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). The technological advancements in antibody therapeutics have led to the development of more efficient antibody therapeutics, hence, driving the growth in the next-generation antibody therapeutics market. However, stringent government regulation, high cost and time required for research and development activities are some of the factors hindering the growth for global next-generation antibody therapeutics market. Market Segmentation: Based o

Statins Can Cause Diabetes…Health regulators are including warning to the medicine labels of popular cholesterol-lowering drugs that they might increase blood sugar and possibly cause memory loss. FDA has publicized last week that there has been alterations in the safety information labels of statins of Merck & Co's, AstraZeneca and Pfizer - medicines that are used by millions of Americans. Statins have long proven that it is effective in reducing the risk of heart attack and other heart disorders and, according to FDA, this new development must not scare people into halting the use of the medicines. FDA announced that they know of studies wherein several patients taking statins might have an increased risk of having high sugar levels in the blood and, eventually, of being diagnosed with diabetes. DPRK jams GPS… "The special actions of our revolutionary armed forces will start soon to meet the reckless challenge of the group of traitors.... They will reduce all the rat-like groups and the bases for provocations to ashes in three or four minutes, in much shorter time, by unprecedented peculiar means and methods of our own style." From recent news |GPS jamming signals coming from North Korea has forced South Korea to order its military and civilian air transports to switch on alternative navigational devices to avoid disruption. A Los Angeles man was sentenced to six years in prison last week for his role in a power wheelchair scam, topping what prosecutors say has been a series of Medicare fraud cases.  Medicare Fraud…Whenever you get a payment notice from Medicare review it for errors. The notice shows what Medicare was billed for, what Medicare paid, and what (if anything) you owe. Make sure Medicare was not billed for health care services, medical supplies, or equipment you did not get. Linked to: http://www.ranker.com/list/springhill-group-korea/toffeex http://springhill-group.yolasite.com/ http://us.fotolog.com/springhillgroup/266000000000016012/

Anti-aging without Surgery - Afraid to age but more afraid of knives and undergo surgery? We always look for the best things and best ways on how to avoid looking old. Have you ever wonder how to reclaim your youth while you do not have to go under the knife? For the millions of people that have sun spots and scars on the surface of their skin that become more prevalent with age, Zapiach said laser technology has vastly improved over the past decade, with patients seeing full results in about three months. Patients looking to turn back the hands of time have a non-invasive option that was most commonly associated with pregnancy: ultrasound unlike before when face lifts used to be the way to go for patients looking to tighten up the saggy, loosening of the facial skin that comes with age. All of us will age and as a part of aging process more and more physical features will vanish along the way. We lose volume in places like our eye sockets, cheeks and jaw line. The doctor has the solution for that, Fillers and injectables, although he said that those are temporary. It will last anywhere from six months to a year but will on depend on the one you choose. A non-invasive procedure that uses a patient's own fat is permanent though. But the doctor warned that not everyone is a candidate for non-invasive procedures. Dr. Zapiach also cautioned that patients with advanced aging may have to resort to surgical options. "Ultherapy actually has an indication to lift and tighten that area . . . as well as the neck and also the eyebrows," said Zapiach. "We'll see results in the cheeks that it will lift and tighten the cheeks and jowls as well." Cigarette Smoking is Dangerous to your Health! - Smoking effects on the human body are destructive and widespread. The ingredients in cigarette affect everything from the internal functioning of the organs and target the efficiency of the body's immune system. Smoking harms nearly every organ of the body. Smoking

"An increase in brain inflammation, such as that caused by age, diabetes and obesity, is known to increase risk for developing Alzheimer's disease. Now scientists at UK's Southampton University are about to start a three-year study, using brain tissue generously donated by people who died with Alzheimer's disease, to see if inflammation caused by infections such as those of the urinary tract or chest, also speeds up progress of the disease." - medical news today In an announcement released on Wednesday, study leader Delphine Boche, Lecturer in Clinical Neurosciences at Southampton, says: "Many of the known risk factors for Alzheimer's, like age, obesity and diabetes, increase inflammation in the brain and we think that infections could be another risk factor." "There is already evidence that the immune system is on high alert in people with Alzheimer's and we think that an extra trigger, like an infection, could tip the balance and make immune cells switch from being protective to harmful," she adds. Alzheimer's Research UK has already put £300,000 into the project. The money is part of the charity's £20m investment in leading dementia research in the UK. The study started in January 2013, and will add to the growing pile of evidence that shows how the immune system is implicated in Alzheimer's disease. The Southampton team believes that in Alzheimer's, the immune system goes beyond its role as protector of the body and starts causing damage, like it does in an autoimmune disease. For their study, Boche and colleagues will use brain tissue generously donated by people who had Alzheimer's disease when they died. With reference to donors' medical records, the researchers will compare the brains of those who had infections when they died with those who did not. They will be particularly interested in immune cells known as "microglia", which go around mopping up cellular debris. They will use fluorescent tags to label the cells in the brain, and look

NBC Bay Area >> A Los Angeles man was sentenced to six years in prison last week for his role in a power wheelchair scam, topping what prosecutors say has been a series of Medicare fraud cases. David James Garrison, 50, a former physician assistant, was found guilty by a federal jury for his role in submitting $18.9 million in fraudulent Medicare claims for power wheelchairs and other equipment. The wheelchair case is the third time Garrison has been accused of Medicare fraud. Garrison's physician assistant license lapsed in 2009, said Russ Heimerich, a spokesman for the Department of Consumer Affairs, which oversees many state licensing boards. He said the board examined the tax evasion case and did not see it as grounds for discipline. According to court documents, Garrison's cases involved the use of "cappers" or "marketers" who recruited Medicare beneficiaries to submit to unneeded care or hand over their personal information. That information was used to bill the program for medications, services or supplies that the patients didn't need. In the wheelchair case, prosecuted by the Los Angeles U.S. attorney's office, one witness testified that marketers had to recruit beneficiaries as far as 300 miles from Los Angeles because so many local people had already been used in other fraud schemes. In the first health fraud case linked to Garrison, he was described as an "at large" suspect in October 2007 when then-Attorney General Jerry Brown announced arrests in a $1.5 million health fraud scam.

Health regulators are including warning to the medicine labels of popular cholesterol-lowering drugs that they might increase blood sugar and possibly cause memory loss. FDA has publicized last week that there has been alterations in the safety information labels of statins of Merck & Co's, AstraZeneca and Pfizer - medicines that are used by millions of Americans. Statins have long proven that it is effective in reducing the risk of heart attack and other heart disorders and, according to FDA, this new development must not scare people into halting the use of the medicines. FDA announced that they know of studies wherein several patients taking statins might have an increased risk of having high sugar levels in the blood and, eventually, of being diagnosed with diabetes. They have apparently known for 4 years now that statin 'slightly' increases blood sugar but they are insisting that this does not change that statins are effective in reducing heart risk for patients. This is the first time that FDA has officially connected the use of statin to cognitive disorders like confusion and forgetfulness, even though several patients have already reported those problems for years. The drugs affected include big brands such as Vytorin, Crestor, Zocor and Lipitor.

After trading blows over the last two decades for supremacy in the consumer electronics market, Samsung Electronics and Sony are set to continue their rivalry in the new arena of medical devices. Only a decade ago, the Japanese company led almost every sector in the information technology industry while its Korean competitor trailed behind trying to catch up. Now, Samsung finds itself ahead in major markets such as smartphones and other consumer electronic goods. It remains to be seen whether Sony can strike back in the medical equipment market, where it's experience and sophistication in optical technology and systems could provide an advantage. Both firms are planning aggressive investment in the business during the second half of the year. Following a change of leadership from Howard Stringer to Kazuo Hirai in April, Sony has been vocal about its intentions to find new growth engines, one of them being the medical business. New CEO Hirai said during his inauguration press conference on April 11 that the company plans to make the medical sector a "business worth 100 billion yen ($1.25 billion) in the mid- and long-term." According to statements released on the same day, Sony has set a sales target of 50 billion yen ($629 million) for its 2014 fiscal-year. It is planning to purchase 58.18 percent share of subsidiary Sony Entertainment, which in turn holds 55.19 percent of M3, a medical service provider. The main motivation behind the purchase is to take managerial control of M3. Out of some 280,000 doctors based in Japan, around 200,000 are reportedly subscribed to an Internet information service offered by M3. The Japanese firm is also planning to buy shares of Shinjuku-based lens maker Olympus, which saw its stock price plummet after admitting guilt to the biggest accounting fraud in the country's history. Olympus makes the best endoscopes in the world, a must-have business for Sony in order to successfully venture into the medical arena. The electronics